Acumen Pharmaceuticals, Inc.

Nasdaq:ABOS

Biological Products, (No Diagnostic Substances)·NEWTON, MA

CEO

Oconnell Daniel Joseph

CFO

Zuga Matt

Financials

18 shown

Type	Period	Ended	Filed
10-Q	Q3 2025	9/30/25	11/12/25	→
10-Q	Q2 2025	6/30/25	8/12/25	→
10-Q	Q1 2025	3/31/25	5/13/25	→
10-K	FY 2024	12/31/24	3/27/25	→
10-Q	Q3 2024	9/30/24	11/12/24	→
10-Q	Q2 2024	6/30/24	8/13/24	→
↓

Earnings Releases (8-K)

20 shown

Filed	Period
11/12/25	Q4 FY2025	→
8/12/25	Q3 FY2025	→
5/13/25	Q2 FY2025	→
3/27/25	Q1 FY2025	→
11/12/24	Q4 FY2024	→
8/13/24	Q3 FY2024	→
↓

News (8-K)

27 shown

Filed	Type	Description
1/12/26	Reg FD	Regulation FD Disclosure	→
11/10/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
7/15/25	Agreement	Entry into a Material Definitive Agreement	→
6/5/25	Vote	Submission of Matters to a Vote of Security Holders	→
6/5/24	Vote	Submission of Matters to a Vote of Security Holders	→
2/1/24	Exec Change	Departure or Appointment of Directors or Certain Officers	→
↓

Prospectuses & Registrations

18 shown

Filed	Form	Description
11/13/25	424B5	424B5	→
4/23/25	ARS	ARS	→
3/27/25	S-8	S-8	→
4/22/24	ARS	ARS	→
3/27/24	S-3	S-3	→
3/27/24	S-8	S-8	→
↓

Filing History(321 filings)

TypeDateAccessionPeriodSize

Mar 10, 2026

0001628280-26-016645FORM 4

Mar 6, 2026

8.3 KB

144

Mar 6, 2026

0001964306-26-000157

—

11.9 KB

Mar 3, 2026

0001628280-26-014365FORM 4

Feb 27, 2026

8.8 KB

144

Feb 27, 2026

0001964306-26-000131

—

11.3 KB

Jan 28, 2026

0001628280-26-003948FORM 4

Jan 26, 2026

13.5 KB

144

Jan 28, 2026

0001964306-26-000061

—

10.6 KB

144

Jan 26, 2026

0001964306-26-000060

—

10.0 KB

Jan 23, 2026

0001628280-26-003349FORM 4

Jan 21, 2026

8.8 KB

Jan 23, 2026

0001628280-26-003348FORM 4

Jan 21, 2026

6.7 KB

Jan 23, 2026

0001628280-26-003347FORM 4

Jan 21, 2026

6.7 KB

Jan 23, 2026

0001628280-26-003346FORM 4

Jan 21, 2026

7.2 KB

Jan 23, 2026

0001628280-26-003344FORM 4

Jan 21, 2026

6.7 KB

144

Jan 23, 2026

0001964306-26-000059

—

9.4 KB

144

Jan 22, 2026

0001964306-26-000058

—

8.7 KB

144

Jan 22, 2026

0001964306-26-000057

—

6.2 KB

144

Jan 22, 2026

0001964306-26-000056

—

7.5 KB

144

Jan 22, 2026

0001964306-26-000055

—

7.5 KB

144

Jan 22, 2026

0001964306-26-000054

—

8.9 KB

Jan 21, 2026

0001628280-26-002962FORM 4

Jan 20, 2026

7.2 KB

Jan 21, 2026

0001628280-26-002961FORM 4

Jan 16, 2026

7.1 KB

Jan 21, 2026

0001628280-26-002960FORM 4

Jan 16, 2026

7.2 KB

Jan 21, 2026

0001628280-26-002959FORM 4

Jan 16, 2026

7.1 KB

Jan 21, 2026

0001628280-26-002958FORM 4

Jan 16, 2026

7.2 KB

Jan 21, 2026

0001628280-26-002957FORM 4

Jan 16, 2026

7.2 KB

Jan 21, 2026

0001628280-26-002956FORM 4

Jan 16, 2026

7.1 KB

25 filings shown

Acumen Pharmaceuticals, Inc.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(321 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
4/23/25	DEFA14A	DEFA14A	→
4/23/25	DEF 14A	DEF 14A	→
4/22/24	DEFA14A	DEFA14A	→
4/22/24	DEF 14A	DEF 14A	→
4/28/23	DEFA14A	DEFA14A	→
4/27/23	DEF 14A	DEF 14A	→
↓

Filed	Form	Description
3/10/26	4	4	→
3/3/26	4	4	→
1/28/26	4	4	→
1/23/26	4	4	→
1/23/26	4	4	→
1/23/26	4	4	→
↓

Filed	Form	Description
3/6/26	144	144	→
2/27/26	144	144	→
1/28/26	144	144	→
1/26/26	144	144	→
1/23/26	144	144	→
1/22/26	144	144	→
↓